These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1829839)

  • 1. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality.
    Trujillo KA; Akil H
    Pharmacol Biochem Behav; 1991 Mar; 38(3):673-5. PubMed ID: 1829839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
    Tzschentke TM; Schmidt WJ
    Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
    Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat.
    Ben-Eliyahu S; Marek P; Vaccarino AL; Mogil JS; Sternberg WF; Liebeskind JC
    Brain Res; 1992 Mar; 575(2):304-8. PubMed ID: 1533339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat.
    Grass S; Hoffmann O; Xu XJ; Wiesenfeld-Hallin Z
    Acta Physiol Scand; 1996 Nov; 158(3):269-73. PubMed ID: 8931770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 potentiates morphine-induced impairment of memory consolidation in mice: involvement of dopaminergic mechanisms.
    Cestari V; Castellano C
    Psychopharmacology (Berl); 1997 Sep; 133(1):1-6. PubMed ID: 9335074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.
    Koek W; France CP
    Psychopharmacology (Berl); 2008 Aug; 199(2):191-8. PubMed ID: 18446324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Katsumata Y; Kameyama T; Yamamoto I; Nabeshima T
    J Neural Transm Gen Sect; 1994; 95(2):137-43. PubMed ID: 7865168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
    Hauber W; Andersen R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):486-90. PubMed ID: 8114947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
    Moore NA; Blackman A; Awere S; Leander JD
    Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception.
    Kest B; Marek P; Liebeskind JC
    Brain Res; 1992 Aug; 589(1):139-42. PubMed ID: 1422813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
    Mehta AK; Ticku MK
    Life Sci; 1990; 46(1):37-42. PubMed ID: 2153885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization.
    Riedinger K; Kulak A; Schmidt WJ; von Ameln-Mayerhofer A
    Behav Brain Res; 2011 Mar; 218(1):194-9. PubMed ID: 21130808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
    Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
    Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical effects of very low dose MK-801.
    Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
    Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.